Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2403)
All Articles published online
|
Feb 7, 2006 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Hilgard P, Kahraman A, Lehmann N, Seltmann C, Beckebaum S, Ross RS, Baba HA, Malago M, Broelsch CE, Gerken G. Cyclosporine |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i5/697.htm |
| Number | Citing Articles |
| 1 |
Roberto J. Firpi, Consuelo Soldevila-Pico, Giuseppe G. Morelli, Roniel Cabrera, Cynthia Levy, Virginia C. Clark, Amitabh Suman, Anthony Michaels, Chaoru Chen, David R. Nelson. The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study. Digestive Diseases and Sciences 2010; 55(1): 196 doi: 10.1007/s10620-009-0981-3
|
| 2 |
Hengli Tang. Cyclophilin Inhibitors as a Novel HCV Therapy. Viruses 2010; 2(8): 1621 doi: 10.3390/v2081621
|
| 3 |
Yu Kihara, Naoto Matsuno, Abuduxukuer Mijiti, Takeshi Nagao, Hironori Takeuchi, Sakae Unezaki, Toshihiko Hirano. Comparative Study of the Cellular Pharmacodynamics of Calcineurin Inhibitors between Patients with Chronic Renal Failure Awaiting Renal Transplantation and Cirrhosis Patients Awaiting Liver Transplantation. Cell Transplantation 2009; 18(5-6): 639 doi: 10.1177/096368970901805-620
|
| 4 |
Alexandra Frey, Katja Piras‐Straub, Andreas Walker, Jörg Timm, Guido Gerken, Kerstin Herzer. The influence of immunosuppressants on direct‐acting antiviral therapy is dependent on the hepatitis C virus genotype. Transplant Infectious Disease 2018; 20(1) doi: 10.1111/tid.12803
|
| 5 |
Marco Antonio Olivera-Martínez, Juan F. Gallegos-Orozco. Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation. Archives of Medical Research 2007; 38(6): 691 doi: 10.1016/j.arcmed.2006.09.003
|
| 6 |
Speranta Iacob, Vito R. Cicinnati, Philip Hilgard, Razvan A. Iacob, Liana S. Gheorghe, Irinel Popescu, Andrea Frilling, Massimo Malago, Guido Gerken, Christoph E. Broelsch, Susanne Beckebaum. Predictors of Graft and Patient Survival in Hepatitis C Virus (HCV) Recipients: Model to Predict HCV Cirrhosis After Liver Transplantation. Transplantation 2007; 84(1): 56 doi: 10.1097/01.tp.0000267916.36343.ca
|
| 7 |
G. C. Sotiropoulos, S. Beckebaum, G. Gerken. Liver and Biliary Tract Surgery. 2006; : 568 doi: 10.1007/978-3-211-49277-2_54
|
| 8 |
Stephen Frausto, Emily Lee, Hengli Tang. Cyclophilins as Modulators of Viral Replication. Viruses 2013; 5(7): 1684 doi: 10.3390/v5071684
|
| 9 |
Robert Flisiak, Anna Parfieniuk. Investigational drugs for hepatitis C. Expert Opinion on Investigational Drugs 2010; 19(1): 63 doi: 10.1517/13543780903431034
|
| 10 |
V. R. CICINNATI, S. IACOB, C. G. KLEIN, H. A. BABA, G. C. SOTIROPOULOS, P. HILGARD, Y. ERIM, C. E. BROELSCH, G. GERKEN, S. BECKEBAUM. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation. Alimentary Pharmacology & Therapeutics 2007; 26(2): 291 doi: 10.1111/j.1365-2036.2007.03363.x
|
| 11 |
Harald Farnik, Christoph Sarrazin. Behandlung von Lebertransplantationspatienten mit chronischer Virushepatitis. Viszeralmedizin 2012; 28(5): 304 doi: 10.1159/000343724
|
| 12 |
Robert C. Huebert, Kymberly D. Watt. Hepatitis C Virus and Liver Transplantation. 2014; : 29 doi: 10.1007/978-1-4614-8438-7_3
|
| 13 |
Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Evidence‐Based Gastroenterology and Hepatology. 2010; : 685 doi: 10.1002/9781444314403.ch42
|
| 14 |
Robert Flisiak, Jean-Maurice Dumont, Raf Crabbé. Cyclophilin inhibitors in hepatitis C viral infection. Expert Opinion on Investigational Drugs 2007; 16(9): 1345 doi: 10.1517/13543784.16.9.1345
|
| 15 |
L.J.W. van der Laan, M. Hudson, S. McPherson, P.E. Zondervan, R.C. Thomas, J. Kwekkeboom, A.S. Lindsay, A.D. Burt, G. Kazemier, H.W. Tilanus, M.F. Bassendine, H.J. Metselaar. Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus. Transplantation Proceedings 2010; 42(10): 4573 doi: 10.1016/j.transproceed.2010.10.013
|
| 16 |
Norah A. Terrault, Mario G. Pessoa. Liver Transplantation. 2009; : 45 doi: 10.1007/978-1-60327-028-1_3
|
| 17 |
J. Guitard, K. Sandres-Sauné, N. Kamar, D. Ribes, S. Faguer, L. Esposito, M. Lavit, F. Muscari, J.M. Péron, L. Lavayssière, D. Durand, L. Rostaing. Hepatitis C Virus Viral Load After Conversion From Tacrolimus to Cyclosporine in Liver Transplant Patients: A Pilot Study. Transplantation Proceedings 2007; 39(8): 2603 doi: 10.1016/j.transproceed.2007.08.086
|
| 18 |
Francisco Sánchez-Bueno, Maria L. Ortiz, Juan Bermejo, Manuel Miras, José A. Pons, Pablo Ramírez, Ricardo Robles, Pascual Parrilla. Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation. Transplant Immunology 2006; 17(1): 47 doi: 10.1016/j.trim.2006.09.029
|
| 19 |
Zhe Liu, John M. Robida, Sreedhar Chinnaswamy, Guanghui Yi, Jason M. Robotham, Heather B. Nelson, Andre Irsigler, C. Cheng Kao, Hengli Tang. Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A. Hepatology 2009; 50(1): 25 doi: 10.1002/hep.22987
|
| 20 |
James R. Burton, Hugo R. Rosen. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transplantation 2006; 12(S2): S38 doi: 10.1002/lt.20944
|